Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 14/20 | 0.47 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.44 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.43 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | BCHE | P06276 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | DRD2 | P14416 | 1/20 | 0.41 |
| ▸ | DRD4 | P21917 | 1/20 | 0.41 |
| ▸ | DRD3 | P35462 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3124946 | 0.94 | OPRM1 (0.52) | OPRM1CHRM1OPRK1OPRL1BCHE | |
| SCHEMBL3142452 | 0.93 | OPRM1 (0.51) | OPRM1CHRM1OPRK1OPRL1DRD2 | |
| SCHEMBL3137562 | 0.92 | OPRM1 (0.48) | OPRM1CHRM1OPRK1OPRL1BCHE | |
| SCHEMBL3138400 | 0.91 | OPRM1 (0.54) | OPRM1CHRM1OPRK1OPRL1KDM4E | |
| SCHEMBL3137583 | 0.89 | OPRM1 (0.47) | OPRM1CHRM1OPRK1OPRL1BCHE | |
| SCHEMBL3132135 | 0.89 | OPRM1 (0.51) | OPRM1CHRM1OPRK1OPRL1BCHE | |
| SCHEMBL3125870 | 0.89 | OPRM1 (0.47) | OPRM1CHRM1OPRK1OPRL1BCHE | |
| SCHEMBL3104314 | 0.89 | AKT1 (0.48) | OPRM1CHRM1OPRK1OPRL1 | |
| SCHEMBL3132392 | 0.89 | OPRM1 (0.46) | OPRM1CHRM1OPRK1OPRL1KDM4E | |
| SCHEMBL3125864 | 0.88 | OPRM1 (0.47) | OPRM1CHRM1OPRK1OPRL1BCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2142528-B1 | 1-(1-BENZYLPIPERIDIN-4-YL)BENZIMIDAZ0LE -5-CARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT OF DIABETES MELLITUS | HOFFMANN LA ROCHE (CH) | 2010-07-07 | — | — | EP | claimed |